Patient-controlled analgesia has successfully made the transition from research tool to clinical acceptability. Reliable and sophisticated patient-controlled analgesia systems are commercially available. The technique has been most used for control of postoperative pain but has been successfully used during labour, after burns and other trauma and in terminal care. Virtually every opioid has been administered by patient-controlled analgesia using almost every route of administration. It is more effective than the traditional techniques of pain control after surgery but is not automatically so. Choice of opioid and the settings chosen for demand dose and lockout interval greatly influence effectiveness. Patient-controlled analgesia requires active participation by the patient but the psychology of patient-controlled analgesia has generally been underestimated. Patient-controlled analgesia has developed empirically and many assumptions have been made; there is a need for fundamental research.
Although patient-controlled analgesia (PCA) has been widely used in the USA and Europe there has been little experience with the technique in Australia; this may change with the introduction of new PCA devices. The development of PCA and clinical experience is reviewed in this paper. In an accompanying paper 1 the pharmacokinetic basis of the technique is considered. In both papers the areas in which information on the subject is lacking are highlighted.
Surveys have found that between onequarter and three-quarters of patients have inadequate pain relief after surgery. 2.3 Why are analgesic drug prescribers and administrators so often unable to match dose with requirement? Both, it would seem, are hobbled by attitudes and beliefs, e.g. addiction potential 4 . 5 and lack of knowledge of drugs and their effects. 45 Complete relief of pain after surgery may not even be a major nursing goal 7 and staff appear unable to assess pain accurately. 3.8 The result is that, when traditional intramuscular analgesia is used, pain is the single most common complaint after surgery.
Infusion analgesia can be an improvement on traditional intermittent intramuscular dosing techniques, but it is not automatically superior and requires that staff adjust rate of administration of analgesic agent appropriately,9.10 i.e. success is still dependent on the skill and judgement of medical and nursing staff. An alternative is to allow the patient to self-administer enough analgesic, when required, to control pain. This is logical since only the patient knows how much relief from pain is obtained from administration of an analgesic agent.
The first recorded use of patient-controlled intravenous-opioid analgesia was during labour. I I The simple apparatus consisted of a hand-held spring-loaded clamp which controlled a pethidine infusion. In 1968 Sechzer described a patient-activated system 'to objectively measure pain'.'2 After surgery patients were given an 'analgesic-demand button' and instructed to press the button repeatedly until the pain was relieved. Each time the button was pressed a nurse-observer administered 1 ml of an analgesic solution and recorded its effect. Pain was estimated from the frequency and timing of button pressing but a by-product of this measurement technique was excellent relief of pain.
The development of equipmentpatient-controlled analgesia
Following these early reports, devices were developed in anaesthetic departmental laboratories to facilitate self-administered analgesia. Sechzer's original device, developed on the promise of his early results, consisted of a fixed rate roller pump and two electro-mechanical timers. ' 3 It contained the most important features of contemporary PCA devices: (1) the patient requested analgesia by pressing a button; (2) a demanddose (controlled by the first timer); (3) a refractory period during which time no further doses could be demanded (controlled by the second timer). Other selfadministration devices were developed soon afterwards; one could even automatically switch between up to four chambers containing different analgesic agents. 14 A device with similar controls, but based on a syringe-driver, was described by Keeri-SzantoY The 'Cardiff Palliator"6 was also based on a driven syringe. It had the controls described above but, for safety, two button presses within one second were required for a demand to be recognised as valid by the electronics: this was to reduce the chances of accidental activation. In 1976, Hull and colleagues constructed a sophisticated microprocessor-con trolled 'i n teracti v e' demand apparatus. 17 Their original device had four cassette tape recorders and was able to 'communicate' with the patient by means of spoken messages. This provided regular prompts to request analgesia (every five minutes) and pOSItIve feedback when a demand for analgesia was recognised as valid.
The voice system was useful in helping some patients in remembering to 'push the button twice', although the electro-mechanical voice technology was unreliable and some patients were irritated by the repetitious messages. 18 The prototype also included a respiratory monitor which suspended drug delivery if respiratory rate fell below a pre-set value. Hull used fentanyl in his system and this meant that some patients needed to make frequent demands for analgesia. If patients fell asleep they might awake in pain -so the system was developed to provide a concurrent continuous background infusion of opioid in which the rate was adjusted automatically to reflect the frequency of demands.
A generation of compact, sophisticated microprocessor-controlled PCA devices have since been developed commercially from these early systems (see Table 1 ). A version of Hull's machine was marketed as the On-demand Analgesic Computer (ODAC, J anssen Scientific Instruments, Beerse, Belgium) but has sinced ceased production. At least six PCA devices are, or soon will be, available in Australia.
The development of PCA technology appears to have followed two main streams. One is the development of increasingly sophisticated bedside drug delivery systems and the other is the production of smaller devices suitable for ambulatory use. The most sophisticated devices can be programmed to administer a range of infusions in response to patients' demands '9 . 21 and even to provide electronic-voice cues 22 (and it is not a large step to the PCA device controlled by verbal requests for pain relief!). Device size and energy source may be important if ambulatory PCA becomes widely utilised. The Leicester Micropalliator 23 and the Cadd-PCA use conventional batteries but systems powered by evaporating liquid flurocarbon 24 and an elastomeric reservoir 25 have also been described (see Table 1 ). Most PCA systems are expensive, although relatively low-cost adaptations of infusion pumps have been produced. 23 . 26
The variables and variants
At a workshop preceding the first meeting on self-administered pain relief in 1984, agreement was reached on terminology associated with patient-controlled analgesia (PCA)Y However, the alternative names 'selfadministered analgesia', 'on-demand analgesia' and 'patient-activated analgesia' continue to be used_ Confusingly, 'on-demand analgesia' is sometimes used to describe the traditional 'PRN' prescription of postoperative analgesia_ The most important variable of PCA is the choice of opioid; the system variables and variants are all dependent on the choice of drug. Each request for analgesia is called a demand_ The system variables of PCA are: Increment the incremental dose administered as a result of a demand_ Only a single 'button press' was required to activate the demand system of the early devices but two 'button presses' were later introduced (Cardiff Palliator and ODAC)_ The safety of two button presses has been recommended;27 however, most recently developed devices have reverted to a single button press_ A single press makes accidental demands more likely but it is possible that a few patients cannot Anaesthesia and Intensive Care. Vol. 16 the minimum interval before a subsequent demand is allowed_ A maximum dose rate can be prescribed on some equipment-A demand during the lockout interval is called an early demand; frequent early demands suggest either the dose increment is too small or the lockout interval is too long_ When the PCA devices requires two button presses for a valid demand, a single button press is called afaulty demand; frequent faulty demands may indicate sedation or disorientation_ 29 Variants of PCA include an infusion under the control of either the physician only (mandatory fixed-rate) or under hybrid control of physician and patient (variable rate)_ If analgesics having brief durations of pharmacodynamic effect are used (e_g_ fentanyl), a background infusion appears necessary, otherwise if the patient falls asleep, he/she may be woken by pain and will need to make several demands, subject to the lockout interval, to re-establish control of pain_ The contribution of a background infusion to provision of analgesia is uncleac 10.23 Although a concurrent infusion buffers the decline in plasma concentration following eac.h demand, I the inherent safety of peA IS immediately diminished by mandatory drug administration, i.e. analgesic will continue to be infused even when not required. To overcome this, 'adaptive' variable rate infusions, calculated by a microprocessor to reflect the number of demands made, have been suggested. '8 . 20 Clinical experience with PCA (i) Postoperative pain . It has been suggested that it is better to be In pain than to be killed by the analgesic, so to be of clinical use peA must be an improvement on conventional therapy, yet be at least as safe. 30 peA has been used most frequently after surgery and the majority of reports do i~d.icate that peA is an improvement on tradItIOnal 'PRN' intramuscular dosing. In the earliest comparative study, 40% of patients receivi~g intramuscular pethidine complained of paIn in the 48 hours after surgery compared with 5% of those self-administering their pain relief. 31 Analgesia from intravenous on-demand fentanyl has been reported as superior to intramuscular papaveretum administered 'as necessary' and as good as continuous epidural local analgesia for postoperative pain control. 32 This study also highlighted some of the technical problems associated with the epidural techniques and which caused some of their patients receiving epidural analgesia to have high pa~n scores, again showing that. any . techmql!es of administering analgesIa WhIch reqUIre the intervention of an attendant who may be involved in other tasks cannot always be relied upon.
In an open study of nurse-administered intram uscular and self-administered intravenous pethidine after abdominal surgery,33 there was a striking differ.ence between the two techniques; the patIents receiving traditional therapy were given much less opioid and had much higher pain ~c~res (more pain) than the peA group. In a SImIlar (though small) study, patients recovering from surgery through a flank incision re.ceived either peA or intramuscular analgesIa; the peA group had significantly less pain and less sedation. 34
A double blind comparison of peA with intramuscular morphine has been attempted. 35 Patients received either regular intramuscular morphine and placebo peA or fentanyl by peA and placebo intramuscular injection; the analgesic e~fi~acy of .b<;>th techniques was found to be SImIlar. PethIdIne by peA has also been compared. with intramuscular morphine and sublIngual buprenorphine after abdominal surgery;36 there were no significant differences between the analgesic techniques in respect to pain scores and lung function tests. The authors noted, however, that the patients in their study receiving intramuscular m<;>r~hine 'o.n demand' received much more OPIOld than IS usual elsewhere and pain scores were (presumably as a consequence) lower than previously reported after si.m.ilar surgery3~ ~nd the patients who self-admInIstered pethIdIne in this study had higher pain scores than usually reported with peA. Unfortunately the values for the peA variables in both the above studies may have disadvantaged the technique. In the most recent, and well executed, comparison of peA versus 'conventional analgesia' pain relief was similar with both techniq ues;38 the conventional analgesia was regular intramuscular morphine with frequent intravenous supplements as required! Early claims that peA provided improve.d pain relief with a lower total dose of analgesIc agent than traditional therapy have not been confirmed, probably because there was of~en inadequate intermittent intramuscular dOSIng of patients. 4 . 5 In one study, patients receiying adequate intramuscular therapy were gIven 30% more opioid than required by those controlling their own analgesia 39 but patients may also self-administer a gr~ater am~unt of analgesic agent than they mIght receIve by conventional techniques. After surgery, morphine doses in excess of 100 mg/24 hours by peA are not rare and ar~ not associa~ed with respiratory rate reductIOn or exceSSIve sedation. 40 The very intermittent nature of intramuscular administration can result in ineffective blood concentrations for 65% of the dosing interval 41 unless supplemented by frequent IV dosing when similar pain control to peA can be obtained with a similar dose of drug. 38 PCA is theoretically safer than other techniques of pain control 30 but ventilatory depression is a frequently voiced concern with PCA. An early study, in which serial measurements in arterial carbon dioxide tension were made during PCA with fentanyl, did not show evidence of respiratory depression. 32 This is in contrast to the incidence of small tidal volumes, apnoea and oxygen desaturation seen with intramuscular and intravenous infusion opioid analgesia. 42 .43 In a survey of post-surgical patients receiving PCA, Bennett and colleagues made more than 1300 recordings of respiratory rate and found no patient to have a rate below 12 breaths per minute. 44 When PCA with fentanyl was compared with intramuscular analgesia, epidural morphine and intercostal nerve block, the PCA treated group had better pain relief but had a slightly larger number of patients with elevated capillary carbon dioxide tensions (45-55 mmHg) than those groups receiving intramuscular or epidural opioids. 4445 It is unlikely that any regimen based on contemporary opioids and providing effective analgesia will be free from adverse effects. Indeed a recent comparison of the oxygen saturation of patients receiving opioids epidurally, intramuscularly, or by PCA, revealed all were at risk of developing desaturation. 46 Monitoring of patients should reflect this and observation should include sedation and respiratory rate. 47 A few cases of frank ventilatory depression have been reported during PCA therapy. Some were because PCA was continued during postoperative haemorrhage (the original demand dose becoming a relative overdose when administered to a hypovolaemic patient 48 ); others include inadvertent misprogramming of the PCA device and accidental bolus administration bv staff unfamiliar with the equipment. 49 Th~ safety (and efficiency) of supplementing PCA with a background infusion is in doubt. 48 Equipment failure likely to cause morbidity has been mostly engineered out of the present generation of PCA devices, although they can never be completely fail-safe. The list of problems reported to the Commonwealth Department of Health in the last two years illustrates the wide range of potential Anaesthesia and /ntensil'e Care, Vol. 16 . No. 4, November. 1988 problems with bedside drug delivery devices 5u and the range of problems associated with PCA in particular have been reviewed elsewhere. 4951 It is stressed that a one-way valve should be used with PCA (and possibly all opioid infusions) to prevent back-flow of analgesic up the tubing of a parallel infusion. 52 Problems which may occur with PCA are summarised in Table 2 .
It is clear from the above that both medical and nursing staff using PCA require an initial familiarisation with both the technique and the equipment and an ongoing educational programme if it is to be successful in use and without mishap. It is claimed that PCA reduces by 20% the amount of time spent by nurses on analgesia-related activities. 53 The saving in time is not enough to offset the increased cost of analgesia by PCA. This study compared IM analgesia with PCA; it is likely that similar amounts of nursing time would be consumed by PCA and infusion analgesia.
It would first appear that patients using PCA need to spend more time awake demanding pain relief than those receiving conventional intramuscular therapy. In fact, there is less disturbance of nocturnal sleep during PCA therapy'4 due, at least in part, to better pain control. PCA also appears to produce less interference with spontaneous activity than intramuscular dosing and may enhance spontaneous activity in a significant proportion of patients,54 although the implication that this may positively affect recovery awaits detailed investigation.
Possibly the greatest advantage of PC A over other techniques of opioid analgesia is the minute-to-minute control of drug administration it affords. Thus a patient can rapidly respond to incident pain following movement, coughing, etc. Attitudes of staff and logistics militate against prophylactic analgesia before physiotherapy, toilet or dressing changes -PCA circumvents this deficiency. Opioids do not control phasic visceral pain well (e.g. colicky abdominal pain). Therefore a deficiency of PCA is that patients experiencing such pain might selfadminister excessive analgesic.
Route of administration
Patient-controlled administration of opioid is possible by epiduraV 5 oraV 6 sublinguaV7 subcutaneous 58 and intramuscular 57 . 59 routes as well as intravenously. For routine postoperative use the intravenous route is recommended; there is rapid and consistent onset of effect after each demand and the lockout interval can be kept short. With intramuscular PCA, there is a much longer lag time between dose and effect than with intravenous PCA (and there must be a longer lockout interval) making it more difficult for patients to achieve pain control. 60 Epidural PCA with morphine,61 pethidine 62 and methadone 55 to control both postoperative pain and cancer pain has been successful.
Duration of administration
In most U.K. studies, PCA is administered for 24-48 hours whereas in the U .S. reports frequently refer to 48-96 hours of PCA 25. This may simply reflect investigators' preferences. Data on when it is appropriate to change from parenteral opioids to oral analgesics is lacking. In the authors' institution a consistent reduction in demand rate is used as the guide to cessation of PCA. However, there is a marked di urnal variation in opioid requirements which must be borne in mind.
peA in obstetrics
First used to control labour pain,ll subsequent work confirmed its efficacy in this role l6 and patient satisfaction is extremely high after PCA. During labour, when compared with traditional administration of pethidine, women self-administered significantly less drug and achieved better pain relief. 63 PCA is unlikely to be as effective as epidural analgesia in labour. peA in trauma, burns and myocardial infarction
In special units PCA has been used to control pain from severe trauma 64 and myocardial infarction. 65 Analgesia for pain from burns and during burns dressings can be provided by PCA although very large increments may be required. There are case reports of patients with trauma 66 and burns 67 safely and effectively self-administering morphine by PCA at rates of up to 56 and 108 mg/hour respectively. peA in terminal care PCA has been effectively used to control pain of advanced cancer. Both IV and epidural PCA have been reported with a range of opioids including morphine and methadone. The earliest experience was gained in hospitals 68 but ambulatory PCA is now being used. Small devices specifically designed for this use have been developed;24.25 some are available in Australia (see Table 1 ). It is difficult to maintain peripheral venous access outside hospital so that subcutaneous PCA is an attractive option for analgesic administration. There are, however, no reports of its use in this way. peA in paediatrics
The successful use of PCA by children has recently been reported. 69 The youngest in the series was 11 and the use of PCA in children down to the age of 10 was recommended by the authors. Obviously this field of application requires further investigation.
The psychology of peA
It is frequently assumed that PCA works in a simple relatively consistent fashion for all patients ignoring the impact of patient and socio-cultural characteristics on the efficacy of PC A or only superficially considering them, e.g. a 'possible psychological boost as the patient senses that he is in control of his pain relief'.70 It is well recognised that psychological factors play a significant role in the definition, perception and tolerance of pain, as well as in individual willingness to communicate the discomfort and distress Anaesthesia and Intensh'e Care. Vol. 16, No. 4. November. 1988 caused by pain. 71 . 75 Despite this, few researchers have acknowledged these important implications in relation to PCAa process of pain relief which requires not merely patient co-operation, but full and active participation! It has been observed that not only can the analgesic effect of a given amount of drug be much greater when self-administered as opposed to nurse-injected, but also that the contribution of 'non-pharmacological factors' in accounting for overall drug effectiveness may r.ange from 22_62%. 70 The patients' perception of control over their pain relief is a major 'non-pharmacological factor'. 76 Similarly, anxiety is one characteristic of acute pain and the amount of perceived postoperative pain is directly proportional to the amount of anxiety experienced by the patient. 77 Thus, increasing patients' beliefs in their ability to control their own pain, should result in a decrease both in their levels of anxiety and perceived pain. Concomitantly, this should lead to a reduction in the amount of medication required for pain relief. PCAdosed patients do indeed report much less 'fear of pain' after surgery. 54 This explanation does not account for those patients who, when offered control over their pain relief through use of PCA, refuse to use it and opt for nurse-administration of analgesia instead. The tendency to perceive opportunities for personal control in any situation, is a personality disposition that varies from person to person. 78 Also there is a tendency for people to expect to have no control in a given situation (e.g. in hospital). Therefore, even when avenues of control present, some patients are either unable to recognise them or are unable to believe that those avenues will provide adequate control. Some are frightened by the prospect of controlling administration of drugs such as morphine or pethidine (with all the connotations gleaned from the lay press) to themselves.
Patients' strategies for coping with stress are important after surgery. Patients who utilise an 'avoidance' coping strategy would be unlikely to agree to use PCA and may, in fact, be more distressed postoperatively if required to do SO. 78 On the other hand, patients who Anaesthesia and Intensive Care, Vo!. 16. No. 4. November, 1988 attempt to master their situation by seeking out information preoperatively ('vigilant' coping strategy), would be likely to benefit from the additional control which PCA usage would afford them.79 Patients' coping styles for stress correlates well with effectiveness of PCA. 8o Personality and socio-cultural characteristics as well as other 'nonpharmacological factors' affect drug effectiveness. 68 Many different personality dispositions (e.g. neuroticism, extraversionintroversion) have been shown to influence perception and tolerance of pain. 73 ,81.82 Pertinent cognitive factors include preoperative expectations of postoperative pain, self-efficacy beliefs, the type of coping strategy being used, and the meaning of the surgery for the patient. This includes the extent to which the patient engages in 'catastrophising' thoughts and feelings regarding the operation and their postoperative pain. 75.84.86 Other mediating factors include age, gender, ethnic background and early pain experiences within the family setting. 72.82.85.86 Some patients who use PCA report inadequate pain-relief even though they are in control of itY There may be physical reasons: if the incremental dose prescribed is too small, the patient receives only little or short-lived analgesia and becomes disenchanted with the technique; the incidence of therapeutic failure may then be similar to traditional intramuscular administration. If the dose is too high, patients may associate adverse effects (e.g. nausea and vomiting) with pain relief and prefer pain to those side effects. There are also psychological explanations. It could be that inadequate information was provided preoperatively concerning the safety of the procedure, or that inadequate reassurance was given postoperativeiy that the patients were using the equipment responsibly. It may also reflect an attitudinal bias to tolerate a degree of pain or that pain should follow surgery.88 A few patients may even be exaggerating their pain when reporting it to the hospital staff; women with higher 'Lie' scores (as measured by the Eysenck and Eysenck PEN inventory) tend to exaggerate their pain 73 and there may be other reinforcing factors in the hospital environment (such as extra attention or sympathy) for those who report inadequate pain relief. The psychological issues in PCA are in need of investigation.
Trends in peA research (a) Objective modelling
The proposal that postoperative pain can be measured by the frequency of 'buttonpressing'l2 has been refined by assuming pain to be the difference between comfort from the analgesic administered and discomfort which is to be relieved. The units of the variable have been called 'pangs', i.e. the amount of pain which, when perceived by button-pressing, produces presses at the rate of lIsecond. An arithmetic model based on this concept has been constructed to allow a proportion of the control of analgesic administration to be undertaken by machine. Computer simulations suggest that improved pain relief without loss of safety may come from such hybrid control. 89
(b) Pharmacodynamic investigations
PCA has been used to compare potencies of different opioids. Agents as different as alfentanil and buprenorphine have been used in a variety of devices. The potencies measured by PCA generally, but not always, confirm the equivalence ratios reported from other techniques. 9o Recently it has become apparent that patients are often unable or unwilling to maintain an increased demand rate if the demand dose is small. 87 Thus the demand dose is an important variable in the success of the technique yet the correct demand dose is not known for most of the opioids which have been used. Even for morphine there is debate; Bennett 54 suggests that optimal bolus dose to start with is 1 mg, whereas Rosen reports 2-4 mg as being best. 9l Demand dose size obviously requires further investigation. For example, when the analgesic tramadol was used postoperatively with a demand dose of 9.6 mg, 37.5% of patients reported unsatisfactory pain scores. Subsequently however, when the demand dose of tramadol was increased to 18.5 mg, only 5% of patients had unsatisfactory pain relief. 87 It could be concluded from the first study that tramadol was a poor analgesic whereas the dose was at fault. Reported tables of analgesic effectiveness obtained using only one size of incremental dose are therefore of dubious value.
The demand dose is usually an intravenous bolus, however, short infusions may reduce side effects by reducing the peak plasma concentration and may provide a longer duration of analgesia allowing drugs with shorter half-lives to be used. The Prominject could be programmed to deliver a tail infusion after a bolus in response to a demand. l9 The Graseby PCAS can administer increments either as a bolus or an infusion (see Table 1 ). This aspect of PCA requires investigation before recommendations can be made. 1 Studies on drugs or techniques have mostly used pain scores or requirements for supplementary analgesia (or both) to ascertain efficacy. This method of measurement of pain relief subjects some patients to higher pain scores than others or uses the nursing staff to judge when analgesia is required; PCA can be used to fulfil this function. All patients can then self-administer additional analgesic to make up on shortfall in the agents being tested, and the amount is a direct measure of effectiveness. Using this technique agents whose maximum potency is unknown can ethically be studied. The technique has been used to investigate pain relief from a range of drugs and techniques including epidural opioids,92 from intramuscular administration of opioids,35 from non-steroidal antiinflammatory drugs 48 . 93 and from ketamine 94 (again, the effect of demand dose size is important when interpreting results).
Some conclusions
In studies across the world, PCA has been found an effective technique of systemic opioid administration. It appears that this is because the patient, and not medical or nursing staff, control the rate of drug delivery. However, patients cannot be expected to make frequent demands and, if the incremental dose is too small, the technique will be ineffective. Similarly, although the lockout interval needs to be appropriate to the opioid used, it must not be so long as to discourage the use of the system and thereby reinforce the helplessness of the patient, i.e. even PCA cannot overcome the deficiencies of a poor prescription.
Anaesthesia Gnd Inrensil'e Care. l'·ol. 16 . 1\'0. 4. ,,'ol 'ember, 1988 It is important to recognise that PCA is simply a technique of supplying drugs to the blood and, eventually, to the receptors. Questions about the efficacy and the safety of PCA are really those about therapeutic indices of the analgesic agents used. At present, no agent seems to be outstanding in this respect. 95 PCA thus is only a drug delivery techniquebut one in which efficacy and probably safety are maximised by providing doses as often as, and only when, needed.
There are several PCA devices marketed in Australia and all are expensive. In 'high-risk' patients good pain relief can reduce morbidity and hospital costs;96 PCA may then be an investment. PCA must not be used unthinkingly as an alternative to better education on pain control or more labour intensive techniques such as epidural analgesia which have proven benefits in selected groupS. 96 In the majority of patients undergoing major surgery PCA can be expected to provide good pain relief; further research and much education are needed to make it even better.
